SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-048252
Filing Date
2009-08-07
Accepted
2009-08-07 16:25:29
Documents
10
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09-18493_110q.htm 10-Q 1126769
2 EX-10.1 a09-18493_1ex10d1.htm EX-10.1 20620
3 EX-10.2 a09-18493_1ex10d2.htm EX-10.2 63196
4 EX-10.3 a09-18493_1ex10d3.htm EX-10.3 98628
5 EX-10.4 a09-18493_1ex10d4.htm EX-10.4 506462
6 EX-31.1 a09-18493_1ex31d1.htm EX-31.1 12214
7 EX-31.2 a09-18493_1ex31d2.htm EX-31.2 12207
8 EX-32 a09-18493_1ex32.htm EX-32 6124
9 GRAPHIC g184931kki001.jpg GRAPHIC 1401
10 GRAPHIC g184931kki002.jpg GRAPHIC 4318
  Complete submission text file 0001104659-09-048252.txt   1855835
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 09996052
SIC: 2834 Pharmaceutical Preparations